P Schmiedlin-Ren - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Transplantation|March 1, 1992

Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?J C Kolars, P L Stetson, B D Rush, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997

Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarinsP Schmiedlin-Ren, D J Edwards, M E Fitzsimmons, et al.

Clinical Pharmacology and Therapeutics|October 23, 1997

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporineK S Lown, R R Mayo, A B Leichtman, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Transplantation|March 1, 1992

Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?J C Kolars, P L Stetson, B D Rush, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997

Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarinsP Schmiedlin-Ren, D J Edwards, M E Fitzsimmons, et al.

Clinical Pharmacology and Therapeutics|October 23, 1997

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporineK S Lown, R R Mayo, A B Leichtman, et al.

Pageof 2